Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioLab Holdings
Memphis, Tennessee, USAbiolabholdings.net ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
BioLab Holdings is a regenerative medicine company specializing in the development and manufacturing of advanced wound care products derived from human birth tissues. Based in Memphis, Tennessee, the company focuses on providing high-quality amniotic and placental allografts to support the healing of chronic and surgical wounds. Their product line includes multi-layered membranes and fluid-based biologics designed to serve as natural scaffolds for tissue repair. BioLab Holdings emphasizes rigorous safety standards and clinical efficacy in its mission to improve patient outcomes in dermatology and surgery.
- Therapeutic areas
- OtherEndocrinologyDermatologyCardiovascular
- Modalities
- BiologicHuman Tissue Allograft
- Industry
- Biotech
Beyond the preview
Go deeper on BioLab Holdings.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioLab Holdings.